Back to CS Candriam S.C.A.
SGEN
Showing 0 of 8 quarters
Position history for CSCandriam S.C.A.'s holdings in SEATTLE GENETICS INC
As of its Q3 2020 13F, Candriam S.C.A. held 517,099 shares of SGEN (Seattle Genetics), worth $101.2M. Candriam S.C.A.'s 13F filings listed SGEN from Q1 2019 to Q3 2020, 7 quarterly filings. SGEN was 1.0% of Candriam S.C.A.'s reported 13F portfolio.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.